We are live on
!
Find out more
SCI
SkyBridge Capital II Portfolio holdings
AUM
$10.4M
1-Year Est. Return
32.5%
This Fund
S&P 500
This Quarter
Est. Return
+7.27%
1 Year Est. Return
-32.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$110M
AUM Growth
-$9.19M
(-7.7%)
Cap. Flow
-$14.8M
Cap. Flow
% of AUM
-13.41%
Top 10 Holdings %
Top 10 Hldgs %
42.42%
Holding
30
New
–
Increased
–
Reduced
30
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$707K |
| 2 |
Procter & Gamble
PG
|
+$655K |
| 3 |
Verizon
VZ
|
+$619K |
| 4 |
Pfizer
PFE
|
+$612K |
| 5 |
Williams-Sonoma
WSM
|
+$603K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.97% |
| 2 | Consumer Discretionary | 21.42% |
| 3 | Healthcare | 12.09% |
| 4 | Communication Services | 10.56% |
| 5 | Technology | 7.62% |
Similar funds
WA
HB
TC
VCMGDR
WFA
PSFG
DP
T
SkyBridge Capital II's Q1 2019 Portfolio in Review
As of Q1 2019, SkyBridge Capital II held 30 positions worth $110M, down 7.7% from $119M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
SkyBridge Capital II withdrew a net $14.8M in Q1 2019, reducing 30 holdings. Its largest reduction was Merck, cutting an estimated $707K.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- SkyBridge Capital II's biggest Q1 2019 reduction was Merck, cutting an estimated $707K.
- SkyBridge Capital II's ten largest holdings make up 42% of its $110M portfolio in Q1 2019.
- SkyBridge Capital II opened 0 new positions and closed 0 in Q1 2019.
- SkyBridge Capital II's portfolio value fell 7.7% quarter-over-quarter to $110M.
Based on SkyBridge Capital II's 13F filing for Q1 2019, filed 14 May 2019.